Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason Ferris, James Rucker, Benjamin Mcclure, Allan H. Young, Caroline S Copeland, Adam Winstock
Journal of Psychopharmacology June 7, 2022 DOI: 10.1177/02698811221099650 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 10,293 |
| Population | Past-year LSD users from an international online survey |
| Duration | 12-month recall period |
| Topics | LSD |
| Keywords | Adverse effect Hallucinogen Pharmacology |
| Citations | 42 |
| Key findings | 1.0% of past-year LSD users sought emergency medical treatment, with psychological symptoms like anxiety and panic most common and typically resolving within 24 hours. |
Abstract
Background: Recreational lysergic acid diethylamide (LSD) use is growing in popularity amid increasing research interest on psychedelics and their possible therapeutic potential yet; the potent psychotropic effects of LSD may result in adverse reactions and behaviour.
Aims: This study aimed to investigate the 12-month incidence and nature of LSD-related adverse experiences resulting in emergency medical treatment (EMT) seeking in an international sample of people reporting LSD use.
Methods: We use data from the 2017 Global Drug Survey – a large anonymous online survey on patterns of drug use conducted between November 2016 and January 2017.
Results: Out of 10,293 past-year LSD users, 102 (1.0%) reported seeking EMT, with a per-event risk estimate of 0.2%. Younger age, comorbid mental health conditions and higher frequency of use were associated with increased risk of EMT seeking. The most common symptoms were psychological, including anxiety, panic and confusion, with the most common explanatory factors cited by respondents being poor ‘setting’ and ‘mindset’. Most responders reported feeling back to normal within 24 h, but 11 participants experienced persistent issues after 4 weeks.
Conclusion: The results suggest that LSD is a relatively safe drug in recreational settings. Adverse reactions are typically short-lived, self-limiting and psychological in nature. Sub-optimal set and setting were commonly reported as suspected contributory factors. Within clinical settings, patient screening, preparatory sessions and supervision should reduce these acute risks considerably.
Comparable studies
Other cross-sectional and survey studies on LSD, most cited first.
Citations in the library
Cited by 37
- Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms Journal of Psychopharmacology April 7, 2022
- Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020 Journal of Psychopharmacology March 6, 2023
- Psilocybin history, action and reaction: A narrative clinical review Journal of Psychopharmacology August 31, 2023
- Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably? Psychedelic Medicine June 1, 2024
- Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment. Journal of Psychopharmacology 2025
and 32 more in the library
Cites 35
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects Biological Psychiatry November 29, 2014
and 30 more in the library